PurposeThe repercussions of the “Covid-19 pandemic” have been felt across all the global economies. Therefore, this study evaluates its consequences on the performance of Indian-listed SMEs across the manufacturing, service, and pharmaceutical sectors in terms of financial performance, solvency position, and market performance.Design/methodology/approachThis study selects 100 Indian SMEs that trade their shares on the BSESME exchange. The selected SMEs are divided into three sectors: manufacturing (56), service (35), and pharmaceutical (9). Total revenue, operating profit, net profit ratio, current ratio and market capitalization serve as Performance parameters. These performance indicators are analysed for the periods before the pandemic (2019–20) and during the pandemic (2020–21) using the Wilcoxon signed-rank test.FindingsThe performance of Indian SMEs has been notably affected by the Covid-19 outbreak. The analysis reveals that the financial performance, solvency, and market performance of SMEs in the manufacturing sector drastically dropped during the pandemic period. Additionally, the analysis demonstrates that the performance of SMEs in the service industry has not been considerably impacted. In contrast, the pharmaceutical industry witnessed a significant improvement in its financial and market performance, but faced a substantial fall in its solvency position over the pandemic period.Practical implicationsThis study offers insightful practical implications for policymakers, decision-makers, investors and other stakeholders in the SME context.Originality/valueThis study makes a pioneering attempt to add new insights to the existing body of literature. It presents a sector-by-sector analysis of the impact of the Covid-19 pandemic on Indian SME. This empirical inquiry in the setting of Indian SMEs has not been attempted in the earlier literature.
Read full abstract